Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Efficacy of Cobolimab, Dostarlimab, and Docetaxel in Advanced Non-Small Cell Lung Cancer Post Anti-PD(L)1 Therapy and Chemotherapy

    Not recruiting

    4 1 1 1
    Investigated diseases:
    Belgium Finland France Germany Greece Italy +5
  • A study to evaluate how the body processes zipalertinib in healthy adult men

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study comparing how the body processes GB1211 capsule and tablet forms with and without food in healthy volunteers

    Not recruiting

    1 1 1
    Investigated diseases:
    The Netherlands
  • Study of roginolisib, dostarlimab and docetaxel combination for patients with advanced non-small cell lung cancer who did not respond to previous immunotherapy and chemotherapy

    Not recruiting

    1 1 1 1
    Belgium Italy Spain
  • Study of AMG 193 tablets for patients with advanced non-small cell lung cancer (NSCLC) who have previously received treatment and have MTAP gene deletion

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia France Germany Greece Hungary +6
  • Study on the Safety and Effectiveness of AZD0022 Alone and with Other Cancer Drugs for Adults with KRAS-G12D Mutated Tumors in Lung, Colorectal, and Pancreatic Cancer

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Belgium Italy The Netherlands Poland Spain
  • Study of BT-001 and Pembrolizumab for Patients with Advanced Solid Tumors, Including Sarcoma, Merkel Cell Carcinoma, Melanoma, Breast, and Lung Cancer

    Not recruiting

    2 1 1 1
    Belgium France
  • Study of Durvalumab and Chemo-Immunotherapy for Patients with Stage III Unresectable Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study Comparing Zimberelimab and Domvanalimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Untreated Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Austria Belgium France Germany Italy The Netherlands +2
  • Study Comparing Lazertinib and Subcutaneous Amivantamab with Intravenous Amivantamab for Patients with EGFR-mutated Advanced or Metastatic Non-small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Poland Portugal Spain